<DOC>
	<DOCNO>NCT00287404</DOCNO>
	<brief_summary>Many patient type 2 diabetes difficulty attain cholesterol goal , partly due recommendation fast measurement may practical typical clinical setting . Focus toward therapy shift toward non-fasting assessment little known usefulness approach diabetes , postmeal cholesterol level abnormal . This observational study examine fast postmeal lipid ( cholesterol ) patient type 2 diabetes use standard mean NMR .</brief_summary>
	<brief_title>Measuring Cholesterol Fasting Postmeal State Patients With Type 2 Diabetes</brief_title>
	<detailed_description>Current treatment guideline dyslipidemia focus fast lipid panel , specifically LDL cholesterol ( LDL ) compliance show poor . Therefore , focus shift non-fasting measurement . However , limited data patient type 2 diabetes study need illuminate lipid change occur non-fasting state . This observational study examines fast postprandial lipid patient type 2 diabetes use standard chemical analysis NMR . For comparison , lipid panel obtain baseline 3 hour follow standard meal 30 patient type 2 diabetes . These measurement analyze base current ATP III guideline . We investigate degree postprandial assessment agree fast assessment agreement LDL two alternative measure -- - non-HDL NMR-LDL .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Age 2075 male female Type 2 diabetes Hemoglobin A1C le 9 last measurement ( within 3 month ) Pregnancy NonEnglish speaking . Inability fast 12 hour Hypoglycemia require assistance previous 6 month Unwilling consume standardize meal</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>hyperlipidemia</keyword>
	<keyword>dyslipidemia</keyword>
	<keyword>fast lipid</keyword>
	<keyword>postprandial lipid</keyword>
	<keyword>Non-HDL cholesterol</keyword>
	<keyword>NMR lipoanalysis</keyword>
	<keyword>ATP III guideline</keyword>
</DOC>